This undated handout image obtained March 28, 2021, courtesy of The National Institue of Allergy and Infectious Diseases/ NIH shows a transmission electron microscope image of SARS-CoV-2, the virus that causes Covid-19, isolated from a patient in the US, as virus particles are shown emerging from the surface of cells cultured in the lab, the spikes on the outer edge of the virus particles give coronaviruses their name, crown-like - The novel coronavirus has killed at least 2,777,761 people since the outbreak emerged in China in December 2019, according to a tally from official sources compiled by AFP at 10H00 GMT on March 28, 2021. At least 126,622,220 cases of coronavirus have been registered. The vast majority have recovered, though some have continued to experience symptoms weeks or even months later. (Photo by Handout / National Institute of Allergy and Infectious Diseases / AFP) / RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO /NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES/NIH/HANDOUT " - NO MARKETING - NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS | Photo Credit: HANDOUT
Researchers from the Institut Pasteur, France, have carried out a study that tested the sensitivity of United Kingdom and South African variants of the coronavirus.
For the study, the researchers examined the serum samples of people who have been vaccinated or previously contracted Covid-19.
They compared this sensitivity with that of the reference virus (D614G), which was until recently the most widespread strain in France.
The findings of the study indicated that the UK variant is neutralized to the same degree as D614G. However, the South African variant is less sensitive to neutralising antibodies.
The researchers stressed that to neutralise the South African variant, the antibody concentrations need to be six times higher than for D614G.
This difference in sensitivity was also observed in vaccinated individuals. The authors of the study found that the antibodies in their serum are effective against the UK variant but less so against the South African one.
The results of the study showed that the UK variant (B.1.1.7) was neutralised by 95 per cent (79 out of 83) of the serum of people who had been infected with SARS-CoV-2 and whose samples were taken up to nine months after the onset of symptoms. The same proportions were observed for the D614G strain.
However, the scientists noticed a decline in neutralising activity against the South African variant in 40 per cent of the serum samples of individuals who had been exposed to the virus, for samples taken nine months after the primary infection.
The findings of the study were published in the journal Nature Medicine.
Published on March 30, 2021
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.